Labs / ADME, DMPK & toxicology
PepGen
Boston, MA, United States · pepgen.com
GMP
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
PepGen is a clinical stage biotech company in Boston developing oligonucleotide therapies for severe neuromuscular and neurological diseases. It is advancing an Enhanced Delivery Oligonucleotide platform to improve delivery to muscle and nerve tissues, including programs for myotonic dystrophy type 1 (DM1).
They take quote requests by email.
What they offer
Oligonucleotide therapeutic development
Develops disease-modifying oligonucleotide therapies aimed at the root cause of neuromuscular and neurological diseases.
Enhanced Delivery Oligonucleotide (EDO) platform
Uses a proprietary peptide-based delivery platform designed to improve delivery, uptake, tolerability, and biodistribution of oligonucleotide therapeutics.
Preclinical development
Advances platform technology and product candidates through preclinical research and development.
Clinical development
Advances clinical stage programs for neuromuscular and neurological diseases.
What they work on
- Modalities
- Small molecule, Bispecific, ADC, Peptide, Oligonucleotide, Cell therapy
- Therapeutic areas
- neuromuscular diseases, neurological diseases, myotonic dystrophy type 1 (DM1)
- Sites
- Boston, USA
- Address
- 321 Harrison Ave. 8th Floor Boston, MA 02118
- Founded
- 2009
Similar labs. Evotec, Transcenta Holding, Aurigene Pharmaceutical Services, Integral BioSystems
Found in a contract services directory. Listing built from pepgen.com. Work here? Claim this listing.